Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:6/17/2017
Start Date:March 2013
End Date:April 17, 2017

Use our guide to learn which trials are right for you!

A Prospective Randomized Trial to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction

The primary hypothesis of this study is to determine which of two incision sites
(inframammary fold incision or the lateral radial incision) provides a more robust blood
supply to the skin envelope during nipple-sparing mastectomy with immediate reconstruction.

Following education about the trial and informed consent, patients will be randomized to one
of the two incisions. If their surgeon recommends a particular incision, there is also a
non-randomized cohort. Patients will complete the Breast Q, a questionnaire prior to surgery
and three months after surgery to capture quality of life data. During the surgery,
laser-assisted fluorescent angiography will be performed three times to look at blood
perfusion with the Spy Elite imaging device.

Patients will be required to return for postoperative follow up visits. All patients will be
seen approximately one week, three weeks, and six weeks after surgery. Patients with a
direct implant will finish the study at their three month post-operative visit. Patients
with an expander will finish the study three months after their final implant is placed.


Inclusion Criteria:

- Patient must be scheduled to undergo either a single or bilateral elective
nipple-areola skin sparing mastectomy (NASSM) procedure with planned immediate
reconstruction.

- Karnofsky Performance Scale of at least 80%.

Exclusion Criteria:

- BMI < 18 or > 35

- Breast tissue of > 800 grams or < 100 grams in weight

- History of radiation to the chest wall or breast being studied

- History of allergy to iodides or iodinated contrast agents

- Cognitive impairment

- Surgeon's opinion at the time of surgery that the subject's well-being would be
compromised (e.g. significant comorbidities, intraoperative findings of a higher
stage cancer or other independent acute health problems).
We found this trial at
1
site
1020 North Mason Road
Saint Louis, Missouri 63141
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials